NEW YORK, October, 2025 – Tilray Medical, a division of Tilray Brands, Inc., has announced a strategic expansion into Panama’s medical cannabis market through a new joint venture. The company, in partnership with Top Tech Global Inc., has secured a comprehensive medical cannabis license from Panamanian authorities, marking a significant step in its international growth strategy.
The joint venture, operating as Solana Life Group, received the license from Panama’s National Directorate of Pharmacy and Drugs. This license authorizes the cultivation, manufacturing, import, export, distribution, and sale of medical cannabis products within the country. The partnership aims to leverage Tilray’s global supply chain and Top Tech’s local distribution expertise to enhance patient access to medical cannabis therapies.
With this joint venture partnership, Tilray Medical will leverage both its global expertise, as well as the local expertise of Top Tech to facilitate the launch and ongoing distribution of medical cannabis products across Panama, thereby enhancing access for patients in need,
Tilray has stated it is committed to supporting the Panamanian medical community by providing education and maintaining a reliable supply chain. The company plans to offer a comprehensive portfolio of cannabinoid-based therapies tailored to meet individual patient requirements.
Strategic Partnership and Market Entry
The expansion is facilitated through the partnership with Top Tech Global Inc., a company whose members have extensive experience in medical device distribution dating back to 2014. This local expertise is considered crucial for navigating the Panamanian regulatory landscape and establishing an effective distribution network.
The newly formed Solana Life Group now holds one of the key licenses required to operate in Panama’s regulated medical cannabis sector. This move aligns with the Panamanian government’s establishment of a framework for the medicinal use of cannabis products, a significant development in the region’s healthcare and wellness sectors. For more context on the regulatory environment, you can find further information on Panama’s medical cannabis regulations.
Tilray is committed to supporting the Panamanian medical community by providing education, maintaining a reliable supply chain, and offering a comprehensive portfolio of cannabinoid-based therapies,
This partnership highlights Tilray’s dedication to patient-centric care worldwide and its objective to deliver safe, high-quality cannabis medicines. The company intends to collaborate closely with healthcare professionals, regulatory authorities, and patient advocacy organizations in Panama.
Global Expansion and Medical Cannabis Leadership
The Panama expansion represents a key progression in Tilray Medical’s international strategy. The division has grown from being one of the first approved licensed producers in Canada to building the first GMP-certified cannabis production facilities in Portugal and Germany. Today, Tilray Medical supplies medical cannabis products to patients in over 20 countries worldwide.
This international growth is part of a broader trend of global joint venture partnerships in the healthcare and wellness sectors. Tilray’s portfolio includes several medical cannabis brands such as Tilray Medical, Tilray Craft, Broken Coast, Redecan, Good Supply, and Navcora, all designed to meet diverse patient needs.
This expansion represents a further progression in Tilray’s mission to support patients and healthcare practitioners globally, advancing healthcare through compassion and innovation,
The company’s unprecedented platform supports over 40 brands in more than 20 countries, including comprehensive cannabis offerings, hemp-based foods, and craft beverages. This latest move into the Panamanian market strengthens its position as a leading global lifestyle and consumer packaged goods company.
For more details on Tilray Brands and its operations, visit Tilray.com. The company’s forward-looking statements indicate its focus on successfully launching and distributing cannabis products in Panama while continuing to commercialize new and innovative products worldwide.